Latest Administration News

Kaiser Reef Limited has marked a milestone with a record-breaking first gold pour exceeding 1,200 ounces at the Henty Gold Mine, transforming the company into a multi-asset gold producer with annual output around 30,000 ounces.

Neuren Pharmaceuticals has approved a significant long-term equity incentive plan tied to critical clinical and regulatory milestones for its drug candidate NNZ-2591, reinforcing management’s commitment to shareholder value.

Lucapa Diamond Company Limited’s shares remain suspended following the appointment of voluntary administrators, highlighting severe financial distress and regulatory breaches.

Lucapa Diamond Company and its subsidiaries have appointed voluntary administrators as they embark on a dual-track recapitalisation and sale process to address financial distress.

Constellation Resources Limited is raising approximately $2.52 million through a non-renounceable entitlement offer priced at $0.12 per share, aiming to fund exploration projects in Western Australia and support general working capital.

Restaurant Brands posted a record $1.4 billion in sales for FY24, alongside a 62.6% surge in net profit, despite ongoing inflation and economic uncertainty. The company remains cautious on FY25 guidance but is focused on margin improvement and strategic growth.

Fintech Chain Limited has applied to delist from the ASX, citing low valuation, poor liquidity, and high costs, aiming to unlock growth capital in China and the US.

Alma Metals Limited has announced a pro-rata non-renounceable rights offer to raise approximately $1.06 million, aiming to fund critical drilling and a scoping study at its Briggs Copper Project in Queensland.

Australis Oil & Gas reported a robust 2024 performance with strong safety and environmental records, maintaining strategic focus on its Tuscaloosa Marine Shale asset despite challenging market conditions.

Constellation Resources has withdrawn its initial entitlement offer and launched a revised plan to raise $2.52 million by issuing new shares at a lower price, aiming to fund exploration and working capital.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.

Elixinol Wellness Ltd has raised $1.5 million through a mix of debt and equity to boost automation and expand its key brands, including Healthy Chef and Soul Seeds.